Syros Pharmaceuticals Presents Research On Gene Control In Acute Myeloid Leukemia At AACR Hematologic Malignancies Meeting

Syros Pharmaceuticals, a therapeutics company focused on discovering and developing novel gene control therapies, announced today presentation of research at the American Association of Cancer Research (AACR) Hematologic Malignancies Meeting that highlights gene control as an approach to treating cancer, opening the potential for a new wave of cancer drugs targeting gene control elements.

Help employers find you! Check out all the jobs and post your resume.